Galectin Therapeutics GALT
NASDAQ GALT
$3.90 +0.14 (+3.72%)
At close: Oct 2, 2026 · 4:00 PM EDT

Galectin Therapeutics (GALT) Return on Assets [ROA] (2011 - 2026)

Updated

Galectin Therapeutics' Return on Assets [ROA] was -152.00% in Q2 2026, up 170.85 percentage points from -322.86% a year earlier but down 17.62 percentage points from the prior quarter.

Analysis

Galectin Therapeutics (GALT) Return on Assets [ROA] (2011 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at Galectin Therapeutics came in at -147.40%, up 61.10 percentage points from FY2024.

  • Return on Assets [ROA] shows a five-year change of -87.28 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Assets [ROA] was -208.49% in FY2024 (-44.26 pp), -164.23% in FY2023 (-39.58 pp), -124.65% in FY2022 (-38.78 pp) and -85.86% in FY2021 (-25.75 pp).
  • Quarterly Return on Assets [ROA] has moved between -345.05% (Q1 2025) and -76.79% (Q4 2021) over five years.
  • Compared with a year earlier, Return on Assets [ROA] has increased for three straight quarters, with an average year-over-year change of -5.01 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Assets [ROA] over five years was Q1 2026 (a gain of 210.67 percentage points); the worst was Q1 2025 (a drop of 195.32 percentage points).
  • Per Business Quant data, GALT's Return on Assets [ROA] in the three quarters before Q2 2026 was -134.38% (Q1 2026), -168.47% (Q4 2025) and -253.48% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Galectin Therapeutics 258.62 Mn 258.62 Mn - -152.00%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -152.00%
Mar 31, 2026 -134.38%
Dec 31, 2025 -168.47%
Sep 30, 2025 -253.48%
Jun 30, 2025 -322.86%
Mar 31, 2025 -345.05%
Dec 31, 2024 -205.03%
Sep 30, 2024 -155.05%
Jun 30, 2024 -162.01%
Mar 31, 2024 -149.74%
Dec 31, 2023 -161.36%
Sep 30, 2023 -195.11%
Jun 30, 2023 -196.72%
Mar 31, 2023 -192.39%
Dec 31, 2022 -200.68%
Sep 30, 2022 -164.93%
Jun 30, 2022 -121.34%
Mar 31, 2022 -91.43%
Dec 31, 2021 -76.79%
Sep 30, 2021 -86.28%
API Access

Galectin Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=GALT&period=max&api_key=YOUR_API_KEY